CXCL12 and neoplasm: For instance, in a mouse model of GBM, the SDF-1α inhibitor in combination with VEGF blockade was more efficient in suppressing TAM recruitment, reducing tumor vasculature and improving survival compared with monotherapy of VEGF blockade (136).